Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Oral ribavirin is a highly effective treatment for lower respiratory tract infections due to respiratory syncytial virus or parainfluenza after allogeneic stem cell transplantation

Bone Marrow Transplantation volume 56, pages 511–513 (2021)Cite this article

Subjects

Lower respiratory tract infections (LRTI), due to community acquired respiratory viruses such as respiratory syncytial virus (RSV) and parainfluenza (PIV), in patients after allogeneic hematopoietic stem cell transplantation (allo-SCT) are associated with significant morbidity and mortality. The severity of immunodeficiency is directly associated with a high probability for rapid progression to LTRI, respiratory failure needing mechanical ventilation and a fatal outcome [1].

Shah et al. [2] developed an immunodeficiency scoring index (ISI-RSV) with the aim to predict the risk of progression to LRTI and RSV-associated mortality. Based on the presence or absence of several parameters, patients are stratified into low, moderate, and high-risk group with a probability of progression to LTRI of 7%, 15%, 48%, and RSV-associated mortality of 0%, 3%, and 29%, respectively.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Martino R, Porras RP, Rabella N, Williams JV, Rámila E, Margall N, et al. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transpl. 2005;11:781–96.

    Article  Google Scholar 

  2. Shah DP, Ghantoji SS, Ariza-Heredia E, Shah JN, El Taoum K, Shah PK, et al. Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections. Blood. 2014;123:3263–8.

    Article  CAS  Google Scholar 

  3. Seo S, Campbell A, Xie H, Chien J, Leisenring W, Englund J, et al. Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement. Biol Blood Marrow Transpl. 2013;19:589–96.

    Article  CAS  Google Scholar 

  4. Shah D, Ghantoji SS, Shah JN, El Taoum K, Jiang Y, Popat U, et al. Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections. J Antimicrob Chemother. 2013;68:1872–80.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Second Department of Internal Medicine, ATTIKO General University Hospital, National and Kapodistrian University of Athens, Athens, Greece

    Maria Stamouli, Konstantinos Gkirkas, Spyros Chondropoulos, Angeliki Karagiannidi & Panagiotis Tsirigotis

  2. Department of Hematology and Bone Marrow Transplantation, Evangelismos General Hospital, Athens, Greece

    Ioannis Tsonis, Stavros Gigantes, Ioannis Baltadakis & Dimitrios Karakasis

  3. Department of Bone Marrow Transplantation, Aghia Sophia Children Hospital, Athens, Greece

    Christina Economopoulou & Evgenios Goussetis

  4. Department of Clinical Microbiology, ATTIKO General University Hospital, National and Kapodistrian University of Athens, Athens, Greece

    Nikolaos Siafakas, Spyridon Pournaras & Josef Meletiadis

  5. Forth Department of Internal Medicine, ATTIKO General University Hospital, National and Kapodistrian University of Athens, Athens, Greece

    Anastasia Antoniadou

Authors
  1. Maria Stamouli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ioannis Tsonis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Konstantinos Gkirkas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christina Economopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nikolaos Siafakas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Spyridon Pournaras
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Anastasia Antoniadou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Spyros Chondropoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Angeliki Karagiannidi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Josef Meletiadis
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Stavros Gigantes
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Ioannis Baltadakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Evgenios Goussetis
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Dimitrios Karakasis
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Panagiotis Tsirigotis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Panagiotis Tsirigotis.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stamouli, M., Tsonis, I., Gkirkas, K. et al. Oral ribavirin is a highly effective treatment for lower respiratory tract infections due to respiratory syncytial virus or parainfluenza after allogeneic stem cell transplantation. Bone Marrow Transplant 56, 511–513 (2021). https://doi.org/10.1038/s41409-020-01022-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-020-01022-x

This article is cited by

Search

Advanced search

Quick links